Received: 4 June 2020
Accepted: 1 November 2020
First Online: 13 November 2020
Ethics approval and consent to participate
: An exemption and waiver of consent was approved for this study by the Children’s Hospital of Philadelphia Institutional Review Board (#18–014808) for the conduct of secondary research.
: Not applicable.
: J.C. and J.B. report grant funding from GlaxoSmithKline for research outside of this work. The remaining listed authors declare they have no competing interests.